Trial
NCT00169104
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Amgen
Condition
Metastatic Breast Cancer
Intervention
G-CSF
Why stopped
Closed due to achievement of primary study endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-20